Search results for "Highlights"


 
Results 1 - 10 of about 45 for "Highlights".

Keeping tabs

Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with
May 2019

PPI prophylaxis didn't affect 90-day mortality rates among ICU patients

An accompanying editorial described the study's secondary outcome findings as difficult to interpret but noted that the study highlights the low prevalence of gastrointestinal bleeding in modern ICUs.“ In our
October 2018

Boxed warning added to liver disease drug

The FDA announced on Feb. 1 that it will add a new boxed warning to highlight the correct dosing for obeticholic acid (Ocaliva). ... The new warning will highlight current screening, dosing, and monitoring recommendations in the prescribing information
February 2018

Efficacy, safety of second-line therapies analyzed for two types of IBS

A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
April 2019

ACP Gastroenterology Monthly introduces editorial advisory board

ACP Gastroenterology Monthly is pleased to introduce its editorial advisory board.
March 2017

Beta-blockers linked to better outcomes in some patients with cirrhosis

Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
April 2019

Scores to predict outcomes of upper GI bleeding compared

Researchers calculated three pre-endoscopy scores—admission Rockall, AIMS65, and Glasgow Blatchford—and two postendoscopy scores—full Rockall and PNED.
January 2017

Statins associated with lower risk for postcolonoscopy colorectal cancer

The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
March 2019

Halting one ulcerative colitis treatment after escalating to new drug may be feasible, study finds

Patients with ulcerative colitis treated with 5-aminosalicylates who require escalation to anti-tumor necrosis factor-alpha (anti-TNF) therapy may be able to safely discontinue the first drug.
November 2018

Anticoagulants safe, effective in cirrhosis with portal vein thrombosis, review finds

Researchers analyzed eight studies with 353 patients to assess the effect of low-molecular-weight heparin or warfarin on recanalization, thrombosis progression, and bleeding.
May 2017

Result Page: Prev   1   2   3   4   5   Next